1. Home
  2. RYTM vs HWC Comparison

RYTM vs HWC Comparison

Compare RYTM & HWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • HWC
  • Stock Information
  • Founded
  • RYTM 2008
  • HWC 1883
  • Country
  • RYTM United States
  • HWC United States
  • Employees
  • RYTM N/A
  • HWC N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • HWC Major Banks
  • Sector
  • RYTM Health Care
  • HWC Finance
  • Exchange
  • RYTM Nasdaq
  • HWC Nasdaq
  • Market Cap
  • RYTM 3.8B
  • HWC 4.3B
  • IPO Year
  • RYTM 2017
  • HWC N/A
  • Fundamental
  • Price
  • RYTM $61.74
  • HWC $48.65
  • Analyst Decision
  • RYTM Strong Buy
  • HWC Buy
  • Analyst Count
  • RYTM 12
  • HWC 9
  • Target Price
  • RYTM $74.92
  • HWC $59.78
  • AVG Volume (30 Days)
  • RYTM 940.6K
  • HWC 1.1M
  • Earning Date
  • RYTM 05-06-2025
  • HWC 04-15-2025
  • Dividend Yield
  • RYTM N/A
  • HWC 3.70%
  • EPS Growth
  • RYTM N/A
  • HWC 26.31
  • EPS
  • RYTM N/A
  • HWC 5.42
  • Revenue
  • RYTM $130,126,000.00
  • HWC $1,400,813,000.00
  • Revenue This Year
  • RYTM $43.84
  • HWC $10.76
  • Revenue Next Year
  • RYTM $65.62
  • HWC $5.66
  • P/E Ratio
  • RYTM N/A
  • HWC $8.98
  • Revenue Growth
  • RYTM 68.06
  • HWC 7.53
  • 52 Week Low
  • RYTM $35.17
  • HWC $42.39
  • 52 Week High
  • RYTM $68.58
  • HWC $62.40
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 61.94
  • HWC 44.26
  • Support Level
  • RYTM $59.54
  • HWC $47.51
  • Resistance Level
  • RYTM $62.83
  • HWC $50.53
  • Average True Range (ATR)
  • RYTM 4.27
  • HWC 2.82
  • MACD
  • RYTM 1.00
  • HWC 0.14
  • Stochastic Oscillator
  • RYTM 92.04
  • HWC 51.63

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About HWC Hancock Whitney Corporation

Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business, and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit, and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations, and individuals and provides its customers access to investment advisory and brokerage products.

Share on Social Networks: